Skip to main content

Table 2 Adjusted prevalence of statin eligibility among those not on statins (N = 6043), without (Model I) and with (Model II) adjustment for access/utilization.

From: Cholesterol treatment with statins: Who is left out and who makes it to goal?

 

Model I

Model II

Social Risk Factor

AME

95% CI

P

AME

95% CI

P

Age group

        

   21-34 (reference)

        

   35

7.66

3.11

12.21

<0.01

6.74

2.61

10.88

<0.01

   45

18.96

11.72

26.20

<0.01

16.96

10.16

23.76

<0.01

   55

29.84

21.76

37.93

<0.01

26.90

19.08

34.71

<0.01

   ≥ 65

42.48

34.32

50.65

<0.01

38.28

30.35

46.20

<0.01

Female

-11.54

-12.57

-10.50

<0.01

-11.69

-12.75

-10.63

<0.01

Race/Ethnicity

        

   White (reference)

        

   Black

-0.66

-1.81

0.49

0.26

-0.57

-1.54

0.40

0.25

   Hispanic

-2.62

-3.74

-1.49

0.00

-1.65

-2.99

-0.30

0.02

   Other

1.91

-1.48

5.30

0.27

2.28

-1.14

5.70

0.19

Federal Poverty Level (%)

        

   <100 (reference)

        

   100-149

-2.52

-4.86

-0.19

0.03

-2.22

-4.23

-0.21

0.03

   149-199

-2.53

-5.76

0.70

0.12

-2.17

-5.01

0.66

0.13

   200-299

-3.31

-5.54

-1.08

<0.01

-2.91

-4.90

-0.93

<0.01

   300-499

-5.66

-8.82

-2.49

<0.01

-5.01

-7.80

-2.21

<0.01

   ≥ 500

-3.76

-5.46

-2.06

<0.01

-3.34

-4.79

-1.89

<0.01

Education (years)

        

   <12 (reference)

        

   12

0.10

-1.73

1.93

0.92

-0.05

-1.66

1.56

0.95

   >12

-2.34

-3.90

-0.79

<0.01

-2.09

-3.48

-0.70

<0.01

  1. Notes: AME = adjusted average marginal effect, adjusted % difference from reference group; CI = confidence interval. All analyses adjusted for survey year. Model II also adjusted for insurance, language, usual source of care, and visit number. Source: NHANES 1999-2006